FIELD: chemistry.
SUBSTANCE: invention relates to the new derivative 4-aminomethyl-5-hydroxyindole-3-carboxylate of the general formula I: where; R indicates cyclohexyl, cycloheptyl; R1 indicates C1-C3-alkyl, -CH2-X-phenyl; X indicates NH, O, S; R2 indicates C1-C5-alkyl, R3, R4 have identical value and are selected from C1-C3-alkyl, predominantly, CH3, or R3 and R4 together with a nitrogen atom form -5-10- member heterocycle, which contains 1-2- heteroatom selected from N, O, S or their pharmaceutically acceptable salts, with the exception of 6-bromine-5-hydroxy-4-dimethylaminomethyl-2-phenylthiomethyl-1-cyclohexyl-3-ethoxycarbonylindole, 6-bromine-5-hydroxy-4-dimethylaminomethyl-2-methyl-1-cyclohexyl-3-ethoxycarbonylindole, 6-bromine-5-hydroxy-4-dimethylaminomethyl-2-(piperidinomethyl)-1-cyclohexyl-3-ethoxycarbonylindole, 6-bromine-5-hydroxy-4-dimethylaminomethyl-2-(pirrolidinemethyl)-1-cyclohexyl-3-ethoxycarbonylindole and methyl-1-cyclohexyl-4-piperidinomethyl-6-bromine-5-hydroxy-2-methyl-indole-3-carboxylate. The methods of obtaining compound I are described.
EFFECT: exhibit antiviral activity and can be used for treating influenza of the type A.
5 cl, 2 dwg, 2 tbl, 8 ex
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF 5-HYDROXY-4-AMINOMETHYL-1-CYCLOHEXYL (OR CYCLOHEPTYL)-3-ALKOXYCARBONYLINDOLES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, HAVING ANTIVIRAL ACTIVITY AND METHOD OF PRODUCING SAID COMPOUNDS | 2008 |
|
RU2386616C2 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVES HAVING ANTIVIRAL ACTIVITY | 2013 |
|
RU2552422C2 |
5-SUBSTITUTED INDOLE-3-CARBOXYLIC ACID DERIVATIVES, HAVING ANTIVIRAL ACTIVITY, SYNTHESIS METHOD THEREOF AND USE | 2007 |
|
RU2387642C2 |
INDOLE-3-CARBOXYLIC ACID DERIVATIVE HAVING ANTIVIRAL ACTIVITY ON SARS-CoV-2 | 2022 |
|
RU2820633C1 |
β-CYCLODEXTRINE CLATHRATE COMPLEX WITH 5-HYDROXY-4-AMINOMETHYL-1 -CYCLOHEXYL(OR CYCLOHEPTYL)-3-ALKOXYCARBONYLINDOLE DERIVATIVE, METHOD FOR PREPARING IT (VERSIONS), PHARMACEUTICAL COMPOSITION AND DRUG | 2011 |
|
RU2464042C1 |
SUBSTITUTED ESTERS OF 1H-INDOL-3-CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION, METHOD FOR THEIR PREPARING AND USING | 2006 |
|
RU2323210C9 |
ACTIVE SUBSTANCES, PHARMACEUTICAL COMPOSITION, METHOD OF OBTAINING AND APPLICATION | 2007 |
|
RU2338531C1 |
SUBSTITUTED ESTERS OF 1,2,3,7-TETRAHYDROPYRROLO[3,2-f][1,3]BENZOXAZIN-5-CARBOXYLIC ACIDS, PHARMACEUTICAL COMPOSITION, METHOD FOR THEIR PREPARING (VARIANTS) AND USING | 2006 |
|
RU2323221C9 |
SUBSTITUTED ETHERS OF 5-HYDROXY-1H-INDOL-3-CARBOXYLIC ACID, PHARMACEUTICAL COMPOSITION, METHOD OF OBTAINMENT AND APPLICATION | 2007 |
|
RU2344817C1 |
(3R,4R,5S)-4-ACYLAMINO-5-AMINO-3-(1-ETHYL-PROPOXY)-CYCLOHEX-1-ENE-CARBOXYLIC ACIDS, THEIR ESTERS AND METHOD FOR USING | 2011 |
|
RU2469020C1 |
Authors
Dates
2008-07-27—Published
2006-04-18—Filed